Novartis Pharmaceuticals UK LimitedUK Head OfficeFrimley Business Park FrimleyCamberley Surrey GU16 7SR
+44 1276 692255+44 1276 692508Monday - Friday,8:30 - 17:30
Novartis International AGInvestor RelationsP.O. BoxCH-4002 BaselSwitzerland
+41 61 324 79 email@example.com
Novartis UK Press OfficePress Office enquiries only
+44 1276 firstname.lastname@example.org
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
For enquiries contact
+44 1276 698 email@example.com
Novartis Pharmaceuticals UK Ltd has been certified as one of the Top Employers United Kingdom 2015 for the second year running.
2 March 2015
Novartis announced that it has completed a series of transactions with GlaxoSmithKline plc (GSK), including the acquisition of certain oncology products and pipeline compounds from GSK, the creation of a world-leading consumer healthcare business through a joint venture that combines the two companies' consumer divisions, and the divestiture of the Novartis non-influenza Vaccines business to GSK.
27 January 2014
Novartis has announced the full year results for 2014.
Adverse event reporting
Product Information Leaflets (PILs) for patients
Summary of Product Characteristics (SPC) for Healthcare Professionals